Underreported and underreviewed: Addressing the gaps in TKI tolerability literature for chronic myeloid leukemia
{{output}}
Tyrosine kinase inhibitors have transformed survival in chronic-phase chronic myeloid leukemia, yet long-term treatment success increasingly depends on treatment tolerability. Despite its recognized influence on adherence and quality of life, tolerability rema... ...
